May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Intraocular Pressure-Lowering Monotherapy Does Not Reduce 24-Hour Intraocular Pressure Fluctuation
Author Affiliations & Notes
  • J. H. K. Liu
    Hamilton Glaucoma Center and Dept of Ophthalmology, Univ of California, San Diego, La Jolla, California
  • R. N. Weinreb
    Hamilton Glaucoma Center and Dept of Ophthalmology, Univ of California, San Diego, La Jolla, California
  • Footnotes
    Commercial Relationships  J.H.K. Liu, None; R.N. Weinreb, None.
  • Footnotes
    Support  NIH grant EY07544.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 2049. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. H. K. Liu, R. N. Weinreb; Intraocular Pressure-Lowering Monotherapy Does Not Reduce 24-Hour Intraocular Pressure Fluctuation. Invest. Ophthalmol. Vis. Sci. 2008;49(13):2049.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Lowering intraocular pressure (IOP) with various topical drugs is thought to reduce the IOP fluctuation observed in clinical practice. The present study determined whether or not the 24-hour IOP fluctuation can be reduced by monotherapy of topical prostaglandin analog (latanoprost or travoprost) or beta-blocker (timolol).

Methods: : We reviewed the 24-hour IOP data collected in a sleep laboratory from experimental subjects (age, 40-80 years) before and after receiving at least 4 weeks of latanoprost (N=18), travoprost (N=17), or timolol (N=17). Latanoprost or travoprost was given once daily before bedtime and timolol (Timoptic-XE) once daily in the morning after awakening. Measurements of IOP were taken every 2 hours sitting during the diurnal period (7 AM to 11 PM) and supine during the nocturnal period (11 PM to 7 AM) using a pneumatonometer. Fluctuations of IOP (peaks minus troughs) in the right eyes during the office-hour (9:30 AM, 11:30 AM, 1:30 PM, and 3:30 PM), diurnal, nocturnal, and 24-hour periods before (untreated baseline) and after the monotherapy were compared using the paired t-test.

Results: : The baseline IOP fluctuations during the office-hour, diurnal, nocturnal, and 24-hour periods were in the range of 3.26-4.19 mmHg, 6.35-7.12 mmHg, 3.86-5.35 mmHg, and 8.97-10.38 mmHg, respectively. Monotherapy of latanoprost and travoprost had no significant effect on the IOP fluctuations during these time periods (P>0.05). Timolol monotherapy caused significant reductions of IOP fluctuation during the office-hour period (P<0.01) and the diurnal period (P<0.01), but it had no significant effect during the nocturnal period (P=0.917) or the 24-hour period (P=0.367). All three treatments of latanoprost, travoprost, and timolol reduced the 24-hour IOP means.

Conclusions: : Prostaglandin analog monotherapy had no significant impact on the 24-hour IOP fluctuation in habitual body positions. Although timolol monotherapy caused a significant reduction of IOP fluctuation outside the nocturnal period, it had no significant effect on the 24-hour IOP fluctuation.

Keywords: intraocular pressure • clinical (human) or epidemiologic studies: risk factor assessment • circadian rhythms 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×